APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Second-Generation DNA Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prenatal Second-Generation DNA Sequencing Market Outlook and Growth Opportunities 2026

Report ID 174220010411 April 2026Not stated

Choose your research edition.

Industry ResearchPrenatal Second-Generation DNA Sequencing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Second-Generation DNA Sequencing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prenatal Second-Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Second-Generation DNA Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Second-Generation DNA Sequencing Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Prenatal Second-Generation DNA Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prenatal Second-Generation DNA Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prenatal Second-Generation DNA Sequencing market include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Prenatal Second-Generation DNA Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prenatal Second-Generation DNA Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prenatal Second-Generation DNA Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prenatal Second-Generation DNA Sequencing market.

Prenatal Second-Generation DNA Sequencing Segment by Company

Natera

Labcorp

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Myriad Genetics

GGA

Fulgent Genetics

Rainbow Genomics

BillionToOne

BGI Genomics

Berry Genomics

Annaroad

Weihansi Biomedical Technology

Prenatal Second-Generation DNA Sequencing Segment by Type

Targeted Panels

Exome Sequencing

Others

Prenatal Second-Generation DNA Sequencing Segment by Application

Public Hospitals

Private Hospitals

Prenatal Second-Generation DNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prenatal Second-Generation DNA Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prenatal Second-Generation DNA Sequencing key companies, revenue, market share, and recent developments.

3. To split the Prenatal Second-Generation DNA Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prenatal Second-Generation DNA Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prenatal Second-Generation DNA Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Prenatal Second-Generation DNA Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Second-Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Second-Generation DNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prenatal Second-Generation DNA Sequencing industry.

Chapter 3: Detailed analysis of Prenatal Second-Generation DNA Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prenatal Second-Generation DNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prenatal Second-Generation DNA Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prenatal Second-Generation DNA Sequencing Industry Trends Table 2. Prenatal Second-Generation DNA Sequencing Industry Drivers Table 3. Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges Table 4. Prenatal Second-Generation DNA Sequencing Industry Restraints Table 5. Global Prenatal Second-Generation DNA Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Company (2021-2026) Table 7. Global Prenatal Second-Generation DNA Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prenatal Second-Generation DNA Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Prenatal Second-Generation DNA Sequencing Company, Product Type & Application Table 10. Global Prenatal Second-Generation DNA Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prenatal Second-Generation DNA Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Panels Table 15. Significant Companies of Exome Sequencing Table 16. Significant Companies of Others Table 17. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Type (2021-2026) Table 21. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Public Hospitals Table 23. Significant Companies of Private Hospitals Table 24. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Application (2021-2026) Table 28. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Application (2027-2032) Table 29. Global Prenatal Second-Generation DNA Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Region (2021-2026) Table 32. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Region (2027-2032) Table 34. Global Prenatal Second-Generation DNA Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Prenatal Second-Generation DNA Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Country (2021-2026) Table 37. Global Prenatal Second-Generation DNA Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Country (2027-2032) Table 39. Natera Company Information Table 40. Natera Business Overview Table 41. Natera Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Natera Prenatal Second-Generation DNA Sequencing Product Portfolio Table 43. Natera Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio Table 48. Labcorp Recent Development Table 49. Quest Diagnostics Company Information Table 50. Quest Diagnostics Business Overview Table 51. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 53. Quest Diagnostics Recent Development Table 54. MedGenome Company Information Table 55. MedGenome Business Overview Table 56. MedGenome Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio Table 58. MedGenome Recent Development Table 59. Mayo Clinic Laboratories Company Information Table 60. Mayo Clinic Laboratories Business Overview Table 61. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio Table 63. Mayo Clinic Laboratories Recent Development Table 64. GeneDx Company Information Table 65. GeneDx Business Overview Table 66. GeneDx Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio Table 68. GeneDx Recent Development Table 69. PreventionGenetics Company Information Table 70. PreventionGenetics Business Overview Table 71. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 73. PreventionGenetics Recent Development Table 74. SYNLAB Company Information Table 75. SYNLAB Business Overview Table 76. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio Table 78. SYNLAB Recent Development Table 79. Myriad Genetics Company Information Table 80. Myriad Genetics Business Overview Table 81. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 83. Myriad Genetics Recent Development Table 84. GGA Company Information Table 85. GGA Business Overview Table 86. GGA Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GGA Prenatal Second-Generation DNA Sequencing Product Portfolio Table 88. GGA Recent Development Table 89. Fulgent Genetics Company Information Table 90. Fulgent Genetics Business Overview Table 91. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 93. Fulgent Genetics Recent Development Table 94. Rainbow Genomics Company Information Table 95. Rainbow Genomics Business Overview Table 96. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 98. Rainbow Genomics Recent Development Table 99. BillionToOne Company Information Table 100. BillionToOne Business Overview Table 101. BillionToOne Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio Table 103. BillionToOne Recent Development Table 104. BGI Genomics Company Information Table 105. BGI Genomics Business Overview Table 106. BGI Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 108. BGI Genomics Recent Development Table 109. Berry Genomics Company Information Table 110. Berry Genomics Business Overview Table 111. Berry Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 113. Berry Genomics Recent Development Table 114. Annaroad Company Information Table 115. Annaroad Business Overview Table 116. Annaroad Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio Table 118. Annaroad Recent Development Table 119. Weihansi Biomedical Technology Company Information Table 120. Weihansi Biomedical Technology Business Overview Table 121. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio Table 123. Weihansi Biomedical Technology Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Prenatal Second-Generation DNA Sequencing Product Image Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Prenatal Second-Generation DNA Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Panels Image Figure 8. Exome Sequencing Image Figure 9. Others Image Figure 10. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Prenatal Second-Generation DNA Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Type (2021-2032) Figure 13. Public Hospitals Image Figure 14. Private Hospitals Image Figure 15. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Prenatal Second-Generation DNA Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Application (2021-2032) Figure 18. Global Prenatal Second-Generation DNA Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Prenatal Second-Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Prenatal Second-Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Prenatal Second-Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Prenatal Second-Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Panels
  • Exome Sequencing
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Natera
  • Labcorp
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Myriad Genetics
  • GGA
  • Fulgent Genetics
  • Rainbow Genomics
  • BillionToOne
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prenatal Second-Generation DNA Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prenatal Second-Generation DNA Sequencing Market Dynamics
  1. 2.1 Prenatal Second-Generation DNA Sequencing Industry Trends
  2. 2.2 Prenatal Second-Generation DNA Sequencing Industry Drivers
  3. 2.3 Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Prenatal Second-Generation DNA Sequencing Industry Restraints
3 Prenatal Second-Generation DNA Sequencing Market by Company
  1. 3.1 Global Prenatal Second-Generation DNA Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Prenatal Second-Generation DNA Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Prenatal Second-Generation DNA Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Prenatal Second-Generation DNA Sequencing Company Product Type and Application
  6. 3.6 Global Prenatal Second-Generation DNA Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prenatal Second-Generation DNA Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prenatal Second-Generation DNA Sequencing Market by Type
  1. 4.1 Prenatal Second-Generation DNA Sequencing Type Introduction
  2. 4.1.1 Targeted Panels
  3. 4.1.2 Exome Sequencing
  4. 4.1.3 Others
  5. 4.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Type
  6. 4.2.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Type (2021-2032)
5 Prenatal Second-Generation DNA Sequencing Market by Application
  1. 5.1 Prenatal Second-Generation DNA Sequencing Application Introduction
  2. 5.1.1 Public Hospitals
  3. 5.1.2 Private Hospitals
  4. 5.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application
  5. 5.2.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Prenatal Second-Generation DNA Sequencing Sales Value Share by Application (2021-2032)
6 Prenatal Second-Generation DNA Sequencing Regional Value Analysis
  1. 6.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Prenatal Second-Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Prenatal Second-Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prenatal Second-Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Prenatal Second-Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
7 Prenatal Second-Generation DNA Sequencing Country-level Value Analysis
  1. 7.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prenatal Second-Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prenatal Second-Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prenatal Second-Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Natera
  2. 8.1.1 Natera Company Information
  3. 8.1.2 Natera Business Overview
  4. 8.1.3 Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Natera Prenatal Second-Generation DNA Sequencing Product Portfolio
  6. 8.1.5 Natera Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Quest Diagnostics
  14. 8.3.1 Quest Diagnostics Company Information
  15. 8.3.2 Quest Diagnostics Business Overview
  16. 8.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio
  18. 8.3.5 Quest Diagnostics Recent Developments
  19. 8.4 MedGenome
  20. 8.4.1 MedGenome Company Information
  21. 8.4.2 MedGenome Business Overview
  22. 8.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio
  24. 8.4.5 MedGenome Recent Developments
  25. 8.5 Mayo Clinic Laboratories
  26. 8.5.1 Mayo Clinic Laboratories Company Information
  27. 8.5.2 Mayo Clinic Laboratories Business Overview
  28. 8.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio
  30. 8.5.5 Mayo Clinic Laboratories Recent Developments
  31. 8.6 GeneDx
  32. 8.6.1 GeneDx Company Information
  33. 8.6.2 GeneDx Business Overview
  34. 8.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio
  36. 8.6.5 GeneDx Recent Developments
  37. 8.7 PreventionGenetics
  38. 8.7.1 PreventionGenetics Company Information
  39. 8.7.2 PreventionGenetics Business Overview
  40. 8.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  42. 8.7.5 PreventionGenetics Recent Developments
  43. 8.8 SYNLAB
  44. 8.8.1 SYNLAB Company Information
  45. 8.8.2 SYNLAB Business Overview
  46. 8.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio
  48. 8.8.5 SYNLAB Recent Developments
  49. 8.9 Myriad Genetics
  50. 8.9.1 Myriad Genetics Company Information
  51. 8.9.2 Myriad Genetics Business Overview
  52. 8.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  54. 8.9.5 Myriad Genetics Recent Developments
  55. 8.10 GGA
  56. 8.10.1 GGA Company Information
  57. 8.10.2 GGA Business Overview
  58. 8.10.3 GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GGA Prenatal Second-Generation DNA Sequencing Product Portfolio
  60. 8.10.5 GGA Recent Developments
  61. 8.11 Fulgent Genetics
  62. 8.11.1 Fulgent Genetics Company Information
  63. 8.11.2 Fulgent Genetics Business Overview
  64. 8.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  66. 8.11.5 Fulgent Genetics Recent Developments
  67. 8.12 Rainbow Genomics
  68. 8.12.1 Rainbow Genomics Company Information
  69. 8.12.2 Rainbow Genomics Business Overview
  70. 8.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  72. 8.12.5 Rainbow Genomics Recent Developments
  73. 8.13 BillionToOne
  74. 8.13.1 BillionToOne Company Information
  75. 8.13.2 BillionToOne Business Overview
  76. 8.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio
  78. 8.13.5 BillionToOne Recent Developments
  79. 8.14 BGI Genomics
  80. 8.14.1 BGI Genomics Company Information
  81. 8.14.2 BGI Genomics Business Overview
  82. 8.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  84. 8.14.5 BGI Genomics Recent Developments
  85. 8.15 Berry Genomics
  86. 8.15.1 Berry Genomics Company Information
  87. 8.15.2 Berry Genomics Business Overview
  88. 8.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  90. 8.15.5 Berry Genomics Recent Developments
  91. 8.16 Annaroad
  92. 8.16.1 Annaroad Company Information
  93. 8.16.2 Annaroad Business Overview
  94. 8.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio
  96. 8.16.5 Annaroad Recent Developments
  97. 8.17 Weihansi Biomedical Technology
  98. 8.17.1 Weihansi Biomedical Technology Company Information
  99. 8.17.2 Weihansi Biomedical Technology Business Overview
  100. 8.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio
  102. 8.17.5 Weihansi Biomedical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst